Internal Medicine, Hematology & Oncology · Decatur, IL
NPI
1396701009
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
210 W McKinley Ave, Suite 1
Decatur, IL, 62526
Phone (217) 877-9442
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.0M
297,321 services
Medicare patients, 2024
720
Average age 74
Drug cost, 2024
$5.5M
1,791 prescriptions
Company payments, 2025
$9,120
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sebastien S Kairouz was code J1439 (injection, ferric carboxymaltose, 1 mg), 80,250 times for 47 patients. In total Sebastien S Kairouz billed 297,321 services in 187 codes, and Medicare paid $4.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-02-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 80,250 | 47 | $0.87 | $70K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 20,500 | 136 | $0.10 | $2,053 |
| J0897 Injection, denosumab, 1 mg | Office | 4,620 | 29 | $20.85 | $96K |
| J0185 Injection, aprepitant, 1 mg | Office | 4,160 | 12 | $1.33 | $5,537 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,799 | 43 | $0.09 | $335 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 3,204 | 44 | $0.07 | $228 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2,920 | 14 | $6.18 | $18K |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 1,904 | 12 | $3.49 | $6,638 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,850 | 25 | $0.72 | $1,327 |
| 80053 Clinical Chemistry | Office | 1,482 | 458 | $10.32 | $15K |
| 36415 Venipuncture Blood Collection | Office | 1,407 | 445 | $8.62 | $12K |
| 96375 Injection Administration | Office | 1,365 | 62 | $11.17 | $15K |
| J9190 Injection, fluorouracil, 500 mg | Office | 1,352 | 15 | $2.28 | $3,076 |
| 83735 Clinical Chemistry | Office | 1,286 | 399 | $6.55 | $8,430 |
| 85027 Blood Count | Office | 1,009 | 308 | $6.32 | $6,379 |
By year: 2022 $3.0M for 206,576 services; 2023 $4.3M for 288,893 services; 2024 $4.0M for 297,321 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 1,482 | 458 | $10.32 | $15K |
| 36415 Venipuncture Blood Collection | 1,407 | 445 | $8.62 | $12K |
| 83735 Clinical Chemistry | 1,286 | 399 | $6.55 | $8,430 |
| 85027 Blood Count | 1,009 | 308 | $6.32 | $6,379 |
| 85007 Blood Count | 1,007 | 308 | $3.71 | $3,735 |
| 85025 Blood Count | 641 | 334 | $7.59 | $4,866 |
| 82784 Immunoassay | 611 | 129 | $9.11 | $5,568 |
| 88185 Surgical Pathology Examination | 571 | 20 | $16.86 | $9,628 |
| 83615 Clinical Chemistry | 447 | 203 | $5.92 | $2,646 |
| 82378 Clinical Chemistry | 404 | 153 | $18.58 | $7,506 |
Medicare prescription drug claims, 2024
In 2024, the drug Sebastien S Kairouz prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 205 prescriptions and refills. In total Sebastien S Kairouz wrote 1,791 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 205 | 205 | 34 | $2,751 |
| Anastrozole Generic | 174 | 399 | 46 | $2,156 |
| Ondansetron Hcl Generic | 120 | 120 | 55 | $582 |
| Dexamethasone Generic | 83 | 90 | 25 | $627 |
| Eliquis Apixaban | 57 | 103 | 20 | $56K |
| Warfarin Sodium Generic | 54 | 114 | 11 | $246 |
| Levofloxacin Generic | 51 | 51 | 37 | $342 |
| Xarelto Rivaroxaban | 49 | 81 | Under 11 | $45K |
| Prochlorperazine Maleate Generic | 42 | 43 | 28 | $482 |
| Erleada Apalutamide | 42 | 42 | Under 11 | $594K |
| Acyclovir Generic | 42 | 54 | Under 11 | $313 |
| Revlimid Lenalidomide | 42 | 42 | 12 | $723K |
| Hydroxyurea Generic | 39 | 103 | 14 | $897 |
| Venclexta Venetoclax | 39 | 39 | Under 11 | $559K |
| Tamoxifen Citrate Generic | 33 | 74 | Under 11 | $397 |
Brand drugs: 456 claims; generic drugs: 1,335 claims; opioid claims: 273.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sebastien S Kairouz $9,120 ($9,120 in general payments such as food, travel and fees) from 27 companies. The largest payer was Janssen Biotech, Inc. with $7,842.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 11 | $7,842 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $197 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $152 |
| Daiichi Sankyo Inc. 4568.T | 5 | $112 |
| Abbvie Inc. ABBV | 4 | $90.22 |
| GlaxoSmithKline, LLC. GSK | 3 | $60.63 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $58.09 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $55.59 |
| Merck Sharp & Dohme LLC MRK | 2 | $50.7 |
| Lilly USA, LLC LLY | 2 | $50.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.